Fitzpatrick, Cella, Harper & Scinto LLP Promotes Michael Furrow, Daniel Minion, and Christina Schwarz to Partner and John Kirkland to Counsel

January 2015

NEWS RELEASE
Contacts:
Linda Ficano
Middleberg Communications
lficano@fchs.com
(212) 218-2284

For Immediate Release

Fitzpatrick, Cella, Harper & Scinto LLP Promotes Michael Furrow, Daniel Minion, and Christina Schwarz to Partner and John Kirkland to Counsel

NEW YORK, NY, (December 18, 2014) – Fitzpatrick, Cella, Harper & Scinto, one of the world’s premier intellectual property law firms, is proud to announce that Michael Furrow, Daniel Minion, and Christina Schwarz have been elected partners of the firm, and John Kirkland has been promoted to counsel at the firm, all effective January 1, 2015.
“Michael, Daniel, Christina, and John combine a wealth of sophisticated technical knowledge with sharp legal prowess to provide our clients with the top-notch service they expect from Fitzpatrick,” said Dominick Conde, partner and Member of the Management Committee. “We are pleased they have been elected to our partnership and counsel, as all four have been with the firm for the majority of their careers.”

Michael Furrow, Litigation, New York
Michael Furrow, Ph.D. practices general intellectual property law with an emphasis on complex pharmaceutical and biotechnology patent litigation. He has litigated patent infringement cases pertaining to drugs for treating Alzheimer’s disease, breast cancer, epilepsy, gastric acid-related disorders, HIV/AIDS, and various endocrine and vascular diseases. Dr. Furrow also has experience with contested proceedings before the United States Patent and Trademark Office, pre-suit investigations, non-infringement and validity opinions, and intellectual property due diligence. He received his J.D. from Harvard Law School, his Ph.D. from Harvard University, and his A.B. from Harvard College.

Daniel Minion, Litigation, New York
Daniel Minion’s practice focuses on complex patent litigation with an emphasis on the pharmaceutical and chemical arts. Mr. Minion has counseled clients on a wide range of pharmaceuticals for use in the treatment of breast cancer, renal disease, hypertension, heart disease, diabetes, epilepsy, hormonal disorders, leukemia, osteoporosis, Alzheimer’s, and multiple sclerosis. Prior to law school, Mr. Minion worked as a medicinal chemist for Agouron Pharmaceuticals. He received his J.D. from the Benjamin N. Cardozo School of Law, his M.S. from the University of Pittsburgh, and his B.S. from Stanford University.

Christina Schwarz, Litigation, New York
Christina Schwarz’s practice focuses on complex patent litigation under the Hatch-Waxman Act and contested proceedings before the United States Patent and Trademark Office, including inter partes review proceedings and patent interference proceedings. Ms. Schwarz has experience counseling clients, providing opinions, and working on cases involving a range of pharmaceutical and biotechnology products, including drugs or treatments for renal disease, HCV, Pompe disease, and schizophrenia; modified dosage forms; drug delivery devices; and polymers. In 2007, Ms. Schwarz served as a law clerk to the Honorable Justice Roger T. Hughes of the Federal Court of Canada. She received her J.D. from the University of Western Ontario and both her B.Sc. and M.Sc. from the University of Toronto.

John Kirkland, Litigation, New York
John Kirkland counsels life sciences clients in all aspects of complex patent litigation. He has litigated patent infringement cases involving a number of pharmaceutical and biologic products including drugs or treatments for neurodevelopmental disorders, renal disease, rheumatoid arthritis, stroke, and cancer. Mr. Kirkland’s experience includes providing opinions and conducting intellectual property due diligence. Prior to law school, Mr. Kirkland worked for Merck & Co. as a scientist. While in law school, Mr. Kirkland served as a Notes and Comments Editor of the Arts and Entertainment Law Journal, was a Heyman Scholar, and a member of the Intellectual Property Law Students Association. He received his J.D. from the Benjamin N. Cardozo School of Law and his B.A., magna cum laude, Phi Beta Kappa, from Rutgers University.

About Fitzpatrick:
Fitzpatrick, Cella, Harper & Scinto (www.fitzpatrickcella.com), founded in 1971, is a leading national intellectual property law firm of nearly 150 lawyers with offices in New York, Costa Mesa, California and Washington, D.C. The Firm’s practice covers the spectrum of intellectual property services, including applying for patent and trademark protection, litigation, appeals, interferences, alternative dispute resolution, licensing, opinions, corporate transactions, and due diligence. Fitzpatrick represents an international client base from Fortune 500 companies to start-up companies.